Fusion Pharm Stock Today

FSPM Stock  USD 0.0001  0.00  0.00%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 54

 
High
 
Low
Average
Fusion Pharm is selling at 1.0E-4 as of the 30th of January 2025; that is No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4. Fusion Pharm has 54 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. The performance scores are derived for the period starting the 10th of February 2023 and ending today, the 30th of January 2025. Click here to learn more.
Business Domain
Consumer Staples Distribution & Retail
Category
Healthcare
Classification
Consumer Staples
FusionPharm, Inc. develops, manufactures, and sells a line of cultivation containers under the PharmPod brand name in the United States. The company was founded in 1998 and is based in Commerce City, Colorado. Fusion Pharm operates under Pharmaceutical Retailers classification in the United States and is traded on OTC Exchange. The company has 10.59 M outstanding shares. More on Fusion Pharm

Fusion Stock Highlights

Business ConcentrationConsumer Staples Distribution & Retail, Consumer Staples, Consumer Staples, Consumer Staples Distribution & Retail, Pharmaceutical Retailers, Healthcare (View all Sectors)
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Total Current Liabilities5.3 K5.6 K
Notably Down
Slightly volatile
Total Assets3.4 K3.6 K
Notably Down
Slightly volatile
Total Current Assets3.1 K3.2 K
Notably Down
Slightly volatile
Fusion Pharm (FSPM) is traded on OTCCE Exchange in USA and employs 4 people. Fusion Pharm is listed under Consumer Staples Distribution & Retail category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.06 K. Fusion Pharm conducts business under Consumer Staples Distribution & Retail sector and is part of Consumer Staples industry. The entity has 10.59 M outstanding shares. Fusion Pharm currently holds about 1.45 K in cash with 239.84 K of positive cash flow from operations.
Check Fusion Pharm Probability Of Bankruptcy

Fusion Stock Against Markets

When determining whether Fusion Pharm is a strong investment it is important to analyze Fusion Pharm's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Fusion Pharm's future performance. For an informed investment choice regarding Fusion Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fusion Pharm. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
To learn how to invest in Fusion Stock, please use our How to Invest in Fusion Pharm guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Consumer Staples Distribution & Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fusion Pharm. If investors know Fusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fusion Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.15)
Revenue Per Share
0.133
Return On Assets
(1.38)
The market value of Fusion Pharm is measured differently than its book value, which is the value of Fusion that is recorded on the company's balance sheet. Investors also form their own opinion of Fusion Pharm's value that differs from its market value or its book value, called intrinsic value, which is Fusion Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fusion Pharm's market value can be influenced by many factors that don't directly affect Fusion Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fusion Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fusion Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fusion Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.